Newsroom archive

09 . 04 .2024
News story
An organization built on uniqueness
Galderma’s listing on the SIX Swiss Exchange leading dermatology public company
27 . 03 .2024
News story
Celebrating Galderma’s listing on the SIX Swiss Exchange
Galderma logo
26 . 03 .2024
Press release
Galderma announces full exercise of over-allotment option
  • Key Release
Galderma logo
21 . 03 .2024
Press release
Galderma prices IPO at CHF 53 per share and will start trading on the SIX Swiss Exchange tomorrow
  • Global release
AMWC 2024: Galderma to share new data from its leading injectable aesthetic portfolio
19 . 03 .2024
Press release
AMWC 2024: Galderma to share new data from its leading injectable aesthetic portfolio
  • Global release
AMWC 2024: Scientific presentations
19 . 03 .2024
News story
AMWC 2024: Scientific presentations supported by Galderma
13 . 03 .2024
News story
Dr. Flor A. Mayoral: A story of creativity, passion and dermatological innovation with Galderma
Galderma logo
13 . 03 .2024
Press release
Galderma launches IPO on the SIX Swiss Exchange and sets price range
  • Global release
12 . 03 .2024
News story
We’re inspired by our people
10 . 03 .2024
Press release
Galderma @ AAD 2024: new data demonstrate the long-term efficacy of nemolizumab in prurigo nodularis and its durability in atopic dermatitis
  • Global release